Skip to main content
. 2023 May 17;14:1148209. doi: 10.3389/fimmu.2023.1148209

Figure 9.

Figure 9

Treatment with exendin-4 was accompanied by increased expression of GLP-1R, while treatment with the GLP-1R antagonist, exendin-9-39 (antagonist), did not show this neuroprotective effect in stroke(n=4, *p<0.05, compared to sham-operated group, #p<0.01, compared to the chemical-treated group). Data represent the mean ± SEM. *P<.05; #P<0.01 (132). Figure modified from Open access (Experimental Neurobiology) permissible to re-use under a CC-BY 4.0 license).